Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 134
  2. 135
  3. 136
  4. 137
  5. 138
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Anti-­Mouse CD276 (MJ18) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal MJ18 Mu FC, Blocking Rat ICH1208UL-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Anti-­Mouse CD276 (MJ18) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal MJ18 Mu FC, Blocking Rat ICH1208UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse CD276 (MJ18) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal MJ18 Mu FC, Blocking Rat ICH1208UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209UL-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal 3 Mu FC, Blocking Rat ICH1209UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal YTS191 Mu WB, FC, IHC Rat ICH1210-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Produkt-Datenblatt downloaden Antibody Monoclonal YTS191 Mu WB, FC, IHC Rat ICH1210-25mg

IchorBio 		25 mg Anmelden
Vergleichen
Varokibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5283-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Varokibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5283-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Varokibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5283-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Varokibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5283-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Varokibart Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5283-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Vilamakitug Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5284-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Vilamakitug Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5284-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Vilamakitug Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5284-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Vilamakitug Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5284-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Vilamakitug Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5284-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Vilobelimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5285-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Vilobelimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA CHO cells ICH5285-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Name Preis
Anti-­Mouse CD276 (MJ18) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD276 (MJ18) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone MJ18
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Mouse CD276 (MJ18) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD276 (MJ18) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone MJ18
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse CD276 (MJ18) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD276 (MJ18) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone MJ18
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Mouse CD96 (3.3) In Vivo Antibody -­ Ultra-­Low Endotoxin Anmelden Anti-Mouse CD96 (3.3) In Vivo Antibody - Ultra-Low Endotoxin
Typ Antibody Monoclonal
Clone 3
Specific against Mu
Appl. FC, Blocking
Host Rat
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD4 (YTS191) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone YTS191
Specific against Mu
Appl. WB, FC, IHC
Host Rat
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Mouse CD4 (YTS191) In Vivo Antibody -­ Low Endotoxin Anmelden Anti-Mouse CD4 (YTS191) In Vivo Antibody - Low Endotoxin
Typ Antibody Monoclonal
Clone YTS191
Specific against Mu
Appl. WB, FC, IHC
Host Rat
ArtNr.
Menge 25 mg
Lieferbar
Varokibart Biosimilar -­ Research Grade Anmelden Varokibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Varokibart Biosimilar -­ Research Grade Anmelden Varokibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Varokibart Biosimilar -­ Research Grade Anmelden Varokibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Varokibart Biosimilar -­ Research Grade Anmelden Varokibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Varokibart Biosimilar -­ Research Grade Anmelden Varokibart Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Vilamakitug Biosimilar -­ Research Grade Anmelden Vilamakitug Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Vilamakitug Biosimilar -­ Research Grade Anmelden Vilamakitug Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Vilamakitug Biosimilar -­ Research Grade Anmelden Vilamakitug Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 20 mg
Lieferbar
Vilamakitug Biosimilar -­ Research Grade Anmelden Vilamakitug Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Vilamakitug Biosimilar -­ Research Grade Anmelden Vilamakitug Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Vilobelimab Biosimilar -­ Research Grade Anmelden Vilobelimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 10 mg
Lieferbar
Vilobelimab Biosimilar -­ Research Grade Anmelden Vilobelimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 134
  2. 135
  3. 136
  4. 137
  5. 138
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top